Pregnancy Outcomes in Congenital Myasthenie Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-31

Study Completion Date

2011-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a retrospective study that follows the clinical evolution, the pregnancy and the post-partum perioad of female patients with Congenital Myasthenic Syndrome.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this study is to better understand the action of hormonal factors that are presumably incriminated for the fluctuation of the disease. The investigators would also like to better adress the issues of women with Congenital Myasthenic Syndrome, who desire a pregnancy : the possibility of decompensation, the problems that can arise during the course of the childbearing, the risk of foetal malformations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Myasthenic Syndrome

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Congenital Myasthenic Syndrome Pregnancy Outcome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult women
* Congenital myastenic syndrome genetically confirmed or with clinical compatible and electrophysiological evidence
* Written consent

Exclusion Criteria

* Neurological or general pathology occurs significantly with the initiation and conduct of a pregnancy.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Laurent Servais, M.D.

Laurent SERVAIS MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Laurent SERVAIS, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

institut myologie

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-A00495-34

Identifier Type: -

Identifier Source: org_study_id